AUROPHARMA is currently developing the following drugs: Methacholine Chloride, Albuterol Sulfate Hfa 0.09 Mg (Reference), Albuterol Sulfate Hfa 0.18 Mg (Reference), Albuterol Sulfate Hfa 0.09 Mg (Test), Albuterol Sulfate Hfa 0.18 Mg (Test), Adapalene 0.1% Gel, Differin 0.1% Topical Gel, Test Product, Reference Product. These drug candidates are in various stages of clinical development as the company works toward FDA approval.